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Infectious diseases caused by drug-resistant microorganisms have become a major contributor for human morbidity and 
mortality. To overcome such threats, we have developed various antimicrobial agents using natural product derivatives and 
metallopolymers. Abundant biomass such as resin acids can be utilized to prepare cationic polymers for inhibiting a variety of 
bacteria. These polymers have been used in solution as well as surfaces as antimicrobial materials with low cytotoxicity. In 




The natural evolution of organisms has made the biosphere 
exceptionally diverse. Although most of evolutionary events are 
not evidently visible to us, an observable environmental evolution 
is the adaptation of highly dynamic populations of microorganisms 
such as bacteria toward antibiotics. Constant exposure of bacteria 
to various classes of antimicrobials over the last few decades has 
made a deadly army of multidrug-resistant bacteria, also called 
superbugs, which threaten the wellbeing of humans worldwide. 
Most antimicrobial agents target specific sites in the pathogen 
cells, where many types of resist mechanisms are developed to 
evade them (Figure 1).  
 Despite increasing occurrence of resistance, the discovery of 
novel antimicrobial agents has a sluggish growth. Therefore, it is 
urgent to explore new approaches to solving this pressing issue. 
Among many targets of bacterial cells, the cell membrane is 
thought to be a promising candidate that would have less likelihood 
of developing resistance.2  Hydrophobic alkyl chain containing 
cationic surfactants or detergents are membrane damaging agents 
that are widely used for sterilizing purposes. However, most of 
them show nonspecific toxicity towards mammalian cells and are 
inefficient to selectively destroy multidrug-resistant bacteria. In 
recent years, more attention is given to membrane-active cationic 
antimicrobial polymers that show excellent antimicrobial activity 
while maintaining negligible or no toxicity towards host cells.1, 3-5  
 In our research endeavors, we navigate two paths to develop 
novel and effective antimicrobial agents with low toxicity. In one 
approach, we utilize naturally occurring products such as resin 
acids to make cationic polymers with tunable amphiphilicity to 
selectively target bacterial membranes. On the other hand, we have 
developed synthetic cationic metallopolymers (metal-containing 
polymers) that could be conjugated with traditional antibiotics 
against multidrug resistant bacteria. This short review summarizes 
our own research efforts in innovating antimicrobial polymers 
from the point view of a polymer laboratory.  
 
Antimicrobials by Natural Resin Acids 
 
Resin acids are abundant natural products mostly produced by 
conifer trees in the form of oleoresin or rosin. The worldwide 
production exceeds 1 million tons per year.6, 7 They consist of 
diterpene-based acids such as abietic, levopimaric, and pimaric 
acids. We have developed various types of resin acid-derived 
polymers that showed excellent biodegradability and 
biocompatibility as well as good mechanical properties.8-10 The 
bulky hydrophenanthrene rings of resin acids serve as hydrophobic 
building blocks that can be incorporated into the hydrophobic core 
of bacterial lipid membranes. In one of the studies, abietic acid was  
 
 
Figure 1. (A) Typical antibiotic target sites present in bacterial 
cells, and (B) mechanisms of antibiotic resistance. Reproduced 




modified into a quaternary ammonium containing compound that 
showed outstanding activity against a range of bacteria and high 
selectivity against bacteria over mammalian cells.11 As shown in 
Scheme 1, the synthesis involved a Diels–Alder reaction between 
levopimaric acid and maleic anhydride to produce maleopimaric 
acid, followed by amidation and quaternization reactions. This 
cationic compound was used to functionalize an azide-containing 
polycaprolactone polymer via azide-alkyne ‘click’ chemistry, 
which resulted in a cationic polymer.  
 The antimicrobial activities of the resin acid-derived cationic 
compounds and polymers were investigated against a range of 
pathogenic and non-pathogenic microorganisms. The results 




Scheme 1.  Synthesis of quaternary ammonium-containing 
resin acid-derived antimicrobial compounds and polymers. 
Reproduced by permission of The Royal Society of 
Chemistry.11 




Figure 2. Resin acid-derived antimicrobial  materials  against 
various  pathogens  tested  via  a disk-diffusion method. 
Minimum inhibitory concentrations for (A) Gram-positive and 
(B) Gram-negative bacteria; (C) Images of agar plates obtained 
from the disk-diffusion assay. TEAB = tetraethylammonium 
bromide. Reproduced by permission of The Royal Society of 
Chemistry.11 
 
 In a more recent study, the antimicrobial activity against 
Methicillin-resistant Staphylococcus aureus (MRSA), a complex 
of multidrug-resistant Gram-positive bacterial strains, was 
evaluated.12 The results were unexpectedly promising with 
minimum inhibitory concentrations as low as 5.0 µg/mL for the 
cationic compound and 9.9 µg/mL for the polymer. The 
biocompatibility of these resin-acid derived materials was tested 
against mouse red blood cells and splenocytes. The results proved 
that the cationic materials are largely non-toxic against mammalian 
cells. Molecular dynamics simulations (Figure 3) and dye-leakage 
assays indicated a membrane-lysing eﬀect. We believe that this is 
induced by the unique fused ring structures of resin acids that may 
be the underlying action for selective lysis of bacterial cells over 
mammalian cells. 
 In the previous studies, the cationic charge was designed to 
locate at the periphery of a polymer. The effect of the cationic 
moiety located between the polymer backbone and the 
hydrophobic rosin moiety on antimicrobial efficacy was also 
investigated.13 These novel copolymers (PDMAEM-g-rosin) with 
controlled molecular weight and narrow molecular weight 
distribution were prepared via reversible-addition fragmentation 
transfer (RAFT) polymerization and functionalized using 
quaternization reactions. These cationic polymers exhibited 
effective antibacterial activities against Escherichia coli and S. 
aureus (Figure 4) with the activities dependent on both the degree 
of quaternization of rosin group, the molecular weight of 
copolymers as well as the conformation of hydrophobic group. In 
a control study, PDMAEMA-g-eicosane having a linear alkyl 
chain instead of the rosin moiety was used for the antimicrobial 
assays. It showed no activity against E. coli and only exhibited 
weak activity against S. aureus, suggesting that the activity of 
PDMAEMA-g-rosin was due to not only the hydrophobicity of 
rosin, but also its unique fused-ring structure. 
 Antibacterial, antibiofilm, and biocompatible properties of 
surface-immobilized, quaternary ammonium-containing, resin 
acid-derived compounds and polycations were recently reported 
by our group.14 As shown in the Figure 5, the cationic compound 
and its methacrylate monomer was prepared to modify surface of 
a substrate. 
 Copper-catalyzed azide-alkyne 1,3-dipolar cycloaddition click 
reaction and surface-initiated atom transfer radical polymerization 
were respectively used as chemical tools to graft compounds and  
 
Figure 3.  (A – D) Molecular dynamics simulations snapshots 
of four stages depict cationic compound binding to lipid 
molecules in the model anionic membrane; (E) the resin-acid 
derived compound; (F) Plot of partial densities of lipid 
phosphate head groups along the Z - axis, before and after 
addition of the compound to the system.  Reproduced by 




Figure 4.   FE-SEM images of E. coli (A, B) and S. aureus (C, 
D) bacterial cells before (left) and after (right) treated with 
PDMAEM-g-rosin copolymers. Loss of cellular integrity 
indicated the damages to the cells resulted from the polymers. 





Figure 5.  Surface modification with resin acid derived cationic 
compounds and polymers. Reprinted with permission.14   
Copyright (2015) American Chemical Society. 
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polymers from the substrate surface. Antibacterial and antibiofilm 
activities were tested against Gram-positive S. aureus and Gram-
negative E. coli (Figure 6). 
 In addition to damaging bacteria that attach to the surfaces, these 
modified surfaces damaged planktonic bacterial cells in solution 
that came in contact with them. Furthermore, the biofilm growth 
on these cationic surfaces was considerably reduced as 
demonstrated by CDC bioreactor assays. An improved 
proliferation of human fibroblast cells on the surfaces indicated 
good biocompatibility of these coating materials.  
 
Antimicrobials by Metal-Containing Polymers 
 
Another major initiative in our laboratory is focused on synthetic 
metallopolymers in both synthetic methodology and medicinal 
chemistry. We discovered that cationic metallocene-containing 
polymers and their bioconjugates with conventional antibiotics are 
a new class of antimicrobial agents against multidrug-resistant 
bacteria.15  Due to the exceptional ability of cationic 
cobaltocenium moieties to complex with carboxylate anions, 
cationic cobaltocenium-containing methacrylate polymers were 
prepared and complexed with various β-lactam antibiotics, 
including penicillin, ampicillin, amoxicillin, and cefazolin via ion-
pairing complexation (Figure 8). These conjugated 
metallopolymers were tested against MRSA. Disc-diffusion assays 
indicated that metallopolymers at a concentration of 1-2.2 µM and 
most of the antibiotics alone showed very little inhibition, while 
their bioconjugates exhibits significantly enhanced inhibition 
against different strains of MRSA. Mechanistic investigation 
revealed that these conjugated metallopolymers show high 
efficiency in reducing β-lactamase activity and lyse bacterial cells 
effectively. The β-lactamase enzyme and cell walls of the bacteria 
are attacked by the metallopolymers, and at the same time, the 
conjugated antibiotics are protected via forming ion-pairs with 
cationic cobaltocenium-containing polymers (Figure 7).  
 These antibiotic-metallopolymer bioconjugates demonstrated 
high resistance toward β-lactamase-induced hydrolysis and 
significantly improved efficacy against various strains of MRSA 
cells compared to conventional antibiotics. In addition, these 
metallopolymers, at higher concentrations (≥ 5 µM), also showed 
excellent antimicrobial activities against different strains of MRSA 
by selectively disrupting bacterial cell membranes. Although these 
cationic metallopolymers exhibited excellent efficiency against 
multidrug-resistant MRSA, they showed negligible hemolytic 
effects on red blood cells and minimal in vitro and in vivo toxicity. 
 In another study, we synthesized metallopolymer-containing 
hydrogels (hydrogels are water swelling polymeric networks) for 
healthcare applications.16 Cationic cobaltocenium-containing 
hydrogels were tested for antimicrobial activities against various 
bacteria, including drug-resistant strains. These hydrogels also had 
the similar ability to disrupt negatively charged cell walls of 
bacteria. We found that the metallopolymer hydrogel at a 
concentration of 20 mg/mL showed inhibition of the growth of 
Gram-negative E. coli (90% inhibition), Gram-positive S. 
aureus (80% inhibition), and hospital-acquired methicillin-
resistant S. aureus (HA-MRSA, 80% inhibition).  In addition, 
these hydrogels were also capable of absorbing antibiotics from 
contaminated water, due to the ability of cobaltocenium moieties 
to bind with  β-lactam antibiotics.  
 
CONCLUSIONS 
In summary, we demonstrated that pathogenic bacteria including 
multidrug resistant superbugs can be effectively eliminated by 
multiple strategies that we developed in a polymer laboratory. 
More research will be carried out toward clinical applications of 
these next-generation antimicrobial biomaterials. 
 
 
Figure 6.  Antimicrobial assay results. Stained (Live/Dead 
stain) surfaces after 24 h incubation with (A) S. aureus and (B) 
E. coli. Green cells indicate live bacteria colonizing the 
surface, while dead cells appear in red color. S1: pristine 
surface; S3: compound 1-grafted; and S5: polymer-grafted 
surface. Reprinted with permission.14   Copyright (2015) 
American Chemical Society.   
 
 
Figure 7.  Illustration of several key interactions involving β-
lactamase and β-lactam antibiotics. (A) MRSA cell surface; 
(B) typical β-lactamase hydrolysis of β-lactam antibiotics; 
and (C) Proposed interactions between β-lactam 
antibiotic−metallopolymer bioconjugates, β-lactamase, and 
cell wall. Reprinted with permission.15   Copyright (2015) 
American Chemical Society.   
 
 
Figure 8.  (A) Formation of ion-pairs between β-lactam 
antibiotics and cationic cobaltocenium-containing polymers; 
(B) Four β-lactam antibiotics used in this study; (C) Antibiotic 
release from antibiotic-metallopolymer ion-pairs via 
lipoteichoic acid or β-lactamases. Reprinted with permission.15   
Copyright (2015) American Chemical Society. 
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